Earnings Call Insights: Champions Oncology (CSBR) Q4 fiscal 2026
Management View
-
CEO Robert Brainin said the company delivered “record annual revenue” and “met our commitment to full year positive adjusted EBITDA,” including “positive adjusted EBITDA in each of the 4 quarters on its own, the first
Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.